Navigation Links
SurgiQuest Announces FDA Approval for Smoke & Plume Evacuation for AirSeal Dynamic Pressure System(TM)
Date:2/10/2009

ORANGE, Conn., Feb. 10 /PRNewswire/ -- SurgiQuest, Inc. AirSeal Dynamic Pressure System(TM) was granted FDA 510(k) approval for smoke evacuation. The AirSeal DPS(TM) continuously re-circulates and filters CO2 used to insufflate the abdomen during laparoscopic surgical procedures.

Surgeons routinely have to interrupt laparoscopic surgical procedures due to impaired visualization caused by electrocautery smoke and plume within the operative environment. This impairment restricts access until the smoke is cleared. Often, the smoke is cleared by venting into the operating room in order to regain visualization/access. Continuous evacuation and filtering of smoke, is an integral function of the AirSeal DPS(TM) thereby creating a safer and more efficient working environment for the surgeon, patient and entire operating room staff.

"Our mission has been to improve access and visualization during laparoscopic procedures. One of the key features of the AirSeal DPS(TM) technology is the ability to automatically remove smoke during laparoscopic procedures providing the surgeon unencumbered access while improving visualization," said Kurt Azarbarzin, Founder and CEO of SurgiQuest.

About the AirSeal DPS(TM) access system:

The AirSeal Dynamic Pressure System(TM) provides unprecedented access by eliminating mechanical valves from the cannula and facilitating the introduction of multiple laparoscopic instruments through a single AirSeal(TM) cannula. Additionally; the AirSeal DPS(TM) system provides a proprietary clinical advantage through its ability to simultaneously monitor the insufflator to maintain (pneumoperitoneum) pressure inside the abdomen. This unprecedented, unencumbered approach to MIS is enabling both new procedure development and new instrument platforms geared toward enhancing clinical outcomes.

SurgiQuest, Inc. is a private venture-backed company, founded in May 2006. It develops, manufactures, and markets access technology for minimally invasive surgery.

www.surgiquest.com


'/>"/>
SOURCE SurgiQuest, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SurgiQuest Announces First Single Port Procedure for Uterus and Ovary Removal Using AirSeal(TM) Access System
2. SurgiQuest Announces First Procedure Using AirSeal(TM) Access System
3. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
4. Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
5. Zeus Announces Product Name Changes
6. LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results
7. AMA Announces Physician Class-Actions Against Aetna and CIGNA
8. Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2008 Financial Results
9. Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference
10. Team Finance LLC Announces Fiscal 2008 Financial Results
11. Obesity Society Announces 2009 Call for Abstracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, ... ... a standard process in many scientific laboratories. The assembly protocols involve many repetitive ... is well suited for automation, which enables the high-throughput needed, and results in ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of Pennsylvania ... have made a $10 million gift to establish the Ken Moelis and Julie ... pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as ... they either don’t have access to a health care facility or a pharmacy within 60 ... of the United States or for many who are faced with health or personal issues ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading provider ... a free, public-facing tool for analyzing the costs of various drug regimens in ... information to patients, providers, insurers and pharmaceutical companies about the estimated costs of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
Breaking Medicine Technology: